← FDA DRUG APPROVALS

FDA ANDA · ANDA204166

METHADONE HYDROCHLORIDE

methadone

Sponsor: VISTAPHARM LLC

APPLICATION
ANDA204166
TYPE
ANDA
ORIGINAL APPROVAL
2020-03-16
LATEST ACTION
2026-06-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

METHADONE HYDROCHLORIDEPrescription
METHADONE HYDROCHLORIDE 10MG · TABLET · ORAL

Approval history

2026-06-18REMS · Supplement 11AP
2025-12-23Labeling · Supplement 10 · standardAP
2025-03-27Labeling · Supplement 5 · standardAP
2024-10-31REMS · Supplement 6AP
2023-12-15Labeling · Supplement 4 · standardAP
2023-09-27Labeling · Supplement 2 · standardAP
2021-06-02Labeling · Supplement 1 · standardAP
2020-03-16UNKNOWN · Original · standardREMSAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →